Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer and triple-negative breast cancer have their own genetic, epigenetic, and protein expression profiles. In the present study, based on bioinformatics techniques, we explored the prognostic targets of HER2-positive breast cancer fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Chundi, Li, Huayao, Zhou, Chao, Liu, Cun, Zhuang, Jing, Liu, Lijuan, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161264/
https://www.ncbi.nlm.nih.gov/pubmed/35663326
http://dx.doi.org/10.3389/fendo.2022.813306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161264/
https://www.ncbi.nlm.nih.gov/pubmed/35663326
http://dx.doi.org/10.3389/fendo.2022.813306

Ejemplares similares